Drug intelligence / Profile preview

adiphenine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Adiphenine is a small molecule anticholinergic agent originally introduced as a spasmolytic and local anesthetic. It acts as an antagonist of both nicotinic and muscarinic acetylcholine receptors. Its mechanism involves reducing the frequency of acetylcholine-induced single-channel currents and accelerating desensitization from the open state of the receptor. Adiphenine has been used to reduce muscle tone in the gastrointestinal tract, bile duct and gallbladder, bronchi, bladder; it also affects ocular muscles (causing mydriasis), increases intraocular pressure, induces tachycardia by influencing cardiovascular function, and improves AV conduction. Clinically it has been employed for symptomatic relief in gastrointestinal disorders characterized by spasms (such as gastric/duodenal ulcers), cholelithiasis (gallstones), urinary stones/colic/dysuria/neurogenic bladder conditions. Side effects include nausea, vomiting, heartburn, dizziness and headache. Adiphenine is not widely used clinically today[1][4][5][6].

Brand names
AdiphenDifacilDiphacilPatrovinaSpasmolytinTrasentimeTrasentine
Other names
adiphenine hydrochlorideAdipheaine
02

Targets

mAChR (Muscarinic acetylcholine receptors)Nicotinic Acetylcholine Receptor

Beyond the preview

Go deeper on adiphenine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adiphenine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call